位置:首页 > 蛋白库 > PRIO_AILME
PRIO_AILME
ID   PRIO_AILME              Reviewed;         264 AA.
AC   Q6EH52;
DT   22-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 1.
DT   03-AUG-2022, entry version 75.
DE   RecName: Full=Major prion protein;
DE            Short=PrP;
DE   AltName: CD_antigen=CD230;
DE   Flags: Precursor;
GN   Name=PRNP; Synonyms=PRP;
OS   Ailuropoda melanoleuca (Giant panda).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Carnivora; Caniformia; Ursidae; Ailuropoda.
OX   NCBI_TaxID=9646;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Yang J., Zhao D., Li N.;
RT   "Molecular cloning of prion genes in giant panda.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Its primary physiological function is unclear. Has
CC       cytoprotective activity against internal or environmental stresses. May
CC       play a role in neuronal development and synaptic plasticity. May be
CC       required for neuronal myelin sheath maintenance. May play a role in
CC       iron uptake and iron homeostasis. Soluble oligomers are toxic to
CC       cultured neuroblastoma cells and induce apoptosis (in vitro).
CC       Association with GPC1 (via its heparan sulfate chains) targets PRNP to
CC       lipid rafts. Also provides Cu(2+) or Zn(2+) for the ascorbate-mediated
CC       GPC1 deaminase degradation of its heparan sulfate side chains (By
CC       similarity). {ECO:0000250|UniProtKB:P04156,
CC       ECO:0000250|UniProtKB:P04925}.
CC   -!- SUBUNIT: Monomer and homodimer. Has a tendency to aggregate into
CC       amyloid fibrils containing a cross-beta spine, formed by a steric
CC       zipper of superposed beta-strands. Soluble oligomers may represent an
CC       intermediate stage on the path to fibril formation. Copper binding may
CC       promote oligomerization. Interacts with GRB2, APP, ERI3/PRNPIP and
CC       SYN1. Mislocalized cytosolically exposed PrP interacts with MGRN1; this
CC       interaction alters MGRN1 subcellular location and causes lysosomal
CC       enlargement. Interacts with KIAA1191. {ECO:0000250|UniProtKB:P04156,
CC       ECO:0000250|UniProtKB:P04925}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P04156};
CC       Lipid-anchor, GPI-anchor {ECO:0000250|UniProtKB:P04156}. Golgi
CC       apparatus {ECO:0000250|UniProtKB:P04925}. Note=Targeted to lipid rafts
CC       via association with the heparan sulfate chains of GPC1. Colocates, in
CC       the presence of Cu(2+), to vesicles in para- and perinuclear regions,
CC       where both proteins undergo internalization. Heparin displaces PRNP
CC       from lipid rafts and promotes endocytosis.
CC       {ECO:0000250|UniProtKB:P04156}.
CC   -!- DOMAIN: The normal, monomeric form has a mainly alpha-helical
CC       structure. The disease-associated, protease-resistant form forms
CC       amyloid fibrils containing a cross-beta spine, formed by a steric
CC       zipper of superposed beta-strands. Disease mutations may favor
CC       intermolecular contacts via short beta strands, and may thereby trigger
CC       oligomerization. {ECO:0000250|UniProtKB:P04156}.
CC   -!- DOMAIN: Contains an N-terminal region composed of octamer repeats. At
CC       low copper concentrations, the sidechains of His residues from three or
CC       four repeats contribute to the binding of a single copper ion.
CC       Alternatively, a copper ion can be bound by interaction with the
CC       sidechain and backbone amide nitrogen of a single His residue. The
CC       observed copper binding stoichiometry suggests that two repeat regions
CC       cooperate to stabilize the binding of a single copper ion. At higher
CC       copper concentrations, each octamer can bind one copper ion by
CC       interactions with the His sidechain and Gly backbone atoms. A mixture
CC       of binding types may occur, especially in the case of octamer repeat
CC       expansion. Copper binding may stabilize the conformation of this region
CC       and may promote oligomerization. {ECO:0000250|UniProtKB:P04156}.
CC   -!- DISEASE: Note=Found in high quantity in the brain of humans and animals
CC       infected with degenerative neurological diseases such as kuru,
CC       Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler syndrome (GSS),
CC       scrapie, bovine spongiform encephalopathy (BSE), transmissible mink
CC       encephalopathy (TME), etc. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the prion family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY327449; AAQ93320.1; -; mRNA.
DR   RefSeq; NP_001291815.1; NM_001304886.1.
DR   AlphaFoldDB; Q6EH52; -.
DR   SMR; Q6EH52; -.
DR   GeneID; 100499575; -.
DR   CTD; 5621; -.
DR   InParanoid; Q6EH52; -.
DR   Proteomes; UP000008912; Unassembled WGS sequence.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005507; F:copper ion binding; ISS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.10.790.10; -; 1.
DR   InterPro; IPR000817; Prion.
DR   InterPro; IPR036924; Prion/Doppel_b-ribbon_dom_sf.
DR   InterPro; IPR022416; Prion/Doppel_prot_b-ribbon_dom.
DR   InterPro; IPR025860; Prion_N_dom.
DR   Pfam; PF00377; Prion; 1.
DR   Pfam; PF11587; Prion_bPrPp; 1.
DR   PRINTS; PR00341; PRION.
DR   SMART; SM00157; PRP; 1.
DR   SUPFAM; SSF54098; SSF54098; 1.
DR   PROSITE; PS00291; PRION_1; 1.
DR   PROSITE; PS00706; PRION_2; 1.
PE   2: Evidence at transcript level;
KW   Amyloid; Cell membrane; Copper; Disulfide bond; Glycoprotein;
KW   Golgi apparatus; GPI-anchor; Lipoprotein; Membrane; Metal-binding; Prion;
KW   Reference proteome; Repeat; Signal; Zinc.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000250"
FT   CHAIN           25..241
FT                   /note="Major prion protein"
FT                   /id="PRO_0000042898"
FT   PROPEP          242..264
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000042899"
FT   REPEAT          54..62
FT                   /note="1"
FT   REPEAT          63..70
FT                   /note="2"
FT   REPEAT          71..78
FT                   /note="3"
FT   REPEAT          79..86
FT                   /note="4"
FT   REPEAT          87..94
FT                   /note="5"
FT   REPEAT          95..103
FT                   /note="6"
FT   REGION          25..241
FT                   /note="Interaction with GRB2, ERI3 and SYN1"
FT                   /evidence="ECO:0000250|UniProtKB:P04925"
FT   REGION          28..118
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          54..103
FT                   /note="6 X 8 AA tandem repeats of P-H-G-G-G-W-G-Q"
FT   BINDING         72
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         73
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         74
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         80
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         81
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         82
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         88
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         89
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         90
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         96
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   BINDING         98
FT                   /ligand="Cu(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29036"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000250|UniProtKB:P04156"
FT   LIPID           241
FT                   /note="GPI-anchor amidated alanine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        192
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        208
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        190..225
FT                   /evidence="ECO:0000250|UniProtKB:P04273"
SQ   SEQUENCE   264 AA;  28583 MW;  38C9F5BD98B6092A CRC64;
     MVKSHIGSWI LVLFVAMWSD VGLCKKRPKP GGGWNTGGSR YPGPGSPGGN RYPPQGGGGW
     GQPHGGGWGQ PHGGGWGQPH GGGWGQPHGG GWGQPHGGGG WGQGGTHGQW NKPSKPKTNM
     KHVAGAAAAG AVVGGLGGYM LGSAMSRPLI HFGSDYEDRY YRENMHRYPN QVYYRPVDQY
     SNQNNFVHDC VNITVKEHTV TTTTKGENFT ETDIKMMERV VEQMCITQYQ RESQAYYQRG
     ASVILFSSPP VILLISFLIF LIVG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024